Technology | Mammography | November 22, 2016

Sigmascreening to Introduce Sensitive Sigma Paddle at RSNA 2016

Device has multiple sensors to measure breast size and tissue stiffness for personalized compression during mammography

Sigmascreening, Sensitive Sigma Paddle, mammography, compression, RSNA 2016

November 22, 2016 — Sigmascreening will introduce the Sensitive Sigma Paddle at the upcoming 102nd Annual Radiological Society of North America (RSNA) meeting, Nov. 27-Dec. 2 in Chicago. The Sensitive Sigma Paddle enables personalized compression for better quality mammograms without unnecessary discomfort for patients.

Each year, an estimated 125 million women throughout the world are imaged using mammography. To get the best image quality during a mammogram with the least amount of radiation, the breast needs to be flattened. This is done by compressing the breast. Under-compression can lead to blurred images, more retakes and a higher average glandular dose (AGD), while over-compression causes discomfort and unnecessary pain for the patient. British research estimates that up to 20 percent of screening-eligible women worldwide decide not to have a mammogram because of the pain. This can decrease the rate of early detection, and delay medical treatment of tumors, thus decreasing women's chances of survival.

The patented Sensitive Sigma Paddle has multiple sensors that measure each breast to optimize compression for each breast. Based on breast size and tissue stiffness, the device calculates the pressure to achieve an optimal compression of 75mmHg and allows for a highly reproducible procedure. Sigmascreening said the Sensitive Sigma Paddle is the first pressure-based compression paddle in the market which provides this pressure information real-time.

Investigational in the United States, the device is CE-marked and is actively being used at breast screening centers and hospitals in England, Germany, Sweden, The Netherlands, Belgium and Switzerland since receiving CE-mark last year.

The relationship between pressure applied during compression of the breast and screening performance was recently investigated in the study “Performance of breast screening and cancer detection depends on mammography compression,” which was presented at the 13th International Workshop of Mammographic Imaging in Malmö, June 2016, and published in Breast Imaging. Researchers computed the compression pressure applied to a series of 113,464 screening mammograms. Screening performance measures were determined for each group. Results demonstrated that compression pressures that are too low lead to a higher recall rate and false positives, and compression pressures that are too high reduce detectability of breast cancer. Cancer detection rate and the positive predictive value were optimal in the middle compression category.

For more information: www.sigmascreening.com

Related Content

IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017.

IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017, and who had health records for at least one year prior to the mammogram. The algorithm was trained on 9,611 mammograms. Image courtesy of Radiology.

Feature | Artificial Intelligence | July 19, 2019 | Michal Chorev
Breast cancer is the global leading cause of cancer-related deaths in women, and the most commonly diagnosed cancer...
Paragon Biosciences Launches Qlarity Imaging to Advance FDA-cleared AI Breast Cancer Diagnosis System

Qlarity Imaging’s software is used to assist radiologists in the assessment and characterization of breast lesions. Imaging features are synthesized by an artificial intelligence algorithm into a single value, the QI score, which is analyzed relative to a database of reference abnormalities with known ground truth. Image courtesy of Business Wire.

Technology | Artificial Intelligence | July 18, 2019
Paragon Biosciences LLC announced the launch of its seventh portfolio company, Qlarity Imaging LLC, which was founded...
FDA Clears Koios DS Breast 2.0 AI-based Software
News | Ultrasound Women's Health | July 11, 2019
Koios Medical announced its second 510(k) clearance from the U.S. Food and Drug Administration (FDA).
SimonMed Imaging Implements ProFound AI for 3-D Tomosynthesis
News | Mammography | July 10, 2019
Arizona-based SimonMed Imaging announced their implementation of the first U.S. Food and Drug Administration (FDA)-...
Therapixel Appoints Matthieu Leclerc-Chalvet as CEO
News | Artificial Intelligence | July 03, 2019
Artificial intelligence (AI) breast cancer screening specialist Therapixel announced the appointment of Matthieu...
GE Healthcare showcases Senographe Pristina Serena featuring its add-on-biopsy kit at the Breast Imaging Symposium. Photo by Greg Freiherr

GE Healthcare showcases Senographe Pristina Serena featuring its add-on-biopsy kit at the Breast Imaging Symposium. Photo by Greg Freiherr

Feature | Breast Imaging | July 03, 2019 | By Greg Freiherr
Productivity and its enabler — efficiency — guided the display of products at the April...
Countless possibilities can impact the future of global healthcare and AI is the first step toward breakthrough that will change the landscape of personalized medicine
Feature | Women's Health | July 03, 2019 | By Samir Parikh
Contrary to what many people believe,...

Image courtesy of GE Healthcare

Feature | Radiology Business | July 03, 2019 | By Jeffrey Hoffmeister, M.D.
Burnout in the medical profession is not uncommon, particularly as clinicians have become more overwhelmed by growing
iCAD ProFound AI

Image courtesy of iCAD

News | Breast Imaging | June 25, 2019
Use of...